Literature DB >> 17187497

Adherence to antidepressant treatment.

Hanne Vibe Hansen1, Lars Vedel Kessing.   

Abstract

Depression is a common disorder with painful symptoms and, frequently, social impairment and decreased quality of life. The disorder has a tendency to be long lasting, often with frequent recurrence of symptoms. The risk of relapse and the severity of the symptoms may be reduced by correct antidepressant medication. However, the medication is often insufficient, both in respect to dosage and length of time. The reasons for incorrect medication are many, with lack of adherence to treatment being the most important. Although some patients taking antidepressant medication experience side effects, this may not be the most frequent reason for immature discontinuation of treatment. Other reasons for decreased adherence have been investigated in recent years. The patient's beliefs about the disorder and beliefs about antidepressants, including lack of conviction that the medication is needed and fear of dependence of antidepressant medicine, have a great influence on adherence to treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17187497     DOI: 10.1586/14737175.7.1.57

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  18 in total

1.  Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants.

Authors:  Monique J Bijl; Loes E Visser; Albert Hofman; Arnold G Vulto; Teun van Gelder; Bruno H Ch Stricker; Ron H N van Schaik
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

2.  Non-adherence with psychotropic medications in the general population.

Authors:  Andrew G M Bulloch; Scott B Patten
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-04       Impact factor: 4.328

3.  Road traffic accidents and psychotropic medication use in The Netherlands: a case-control study.

Authors:  Silvia Ravera; Nienke van Rein; Johan J de Gier; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

4.  Adherence to antidepressants among women and men described with trajectory models: a Swedish longitudinal study.

Authors:  Ann-Charlotte Mårdby; Linus Schiöler; Karolina Andersson Sundell; Pernilla Bjerkeli; Eva Lesén; Anna K Jönsson
Journal:  Eur J Clin Pharmacol       Date:  2016-08-03       Impact factor: 2.953

Review 5.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

6.  Primary-care patients' expectations and experiences of online cognitive behavioural therapy for depression: a qualitative study.

Authors:  Angela Beattie; Alison Shaw; Surinder Kaur; David Kessler
Journal:  Health Expect       Date:  2009-03       Impact factor: 3.377

7.  Initiation of antidepressant therapy: do patients follow the GP's prescription?

Authors:  Erica C G van Geffen; Helga Gardarsdottir; Rolf van Hulten; Liset van Dijk; Antoine C G Egberts; Eibert R Heerdink
Journal:  Br J Gen Pract       Date:  2009-02       Impact factor: 5.386

8.  The effects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar affective disorders--design of two randomised clinical trials.

Authors:  Lars Vedel Kessing; Hanne Vibe Hansen; Ellen Margrethe Christensen; Henrik Dam; Christian Gluud; Jørn Wetterslev
Journal:  Trials       Date:  2011-02-03       Impact factor: 2.279

9.  The effects of centralised and specialised intervention in the early course of severe unipolar depressive disorder: a randomised clinical trial.

Authors:  Hanne Vibe Hansen; Ellen Margrethe Christensen; Henrik Dam; Christian Gluud; Jørn Wetterslev; Lars Vedel Kessing
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

10.  Discontinuation of antidepressants: Is there a minimum time on treatment that will reduce relapse risk?

Authors:  Xiaoqin Liu; Natalie C Momen; Nina Molenaar; Anna-Sophie Rommel; Veerle Bergink; Trine Munk-Olsen
Journal:  J Affect Disord       Date:  2021-05-07       Impact factor: 6.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.